Must be a buy, Lopez is back to provide more illogical inanity....

Must be a buy, Lopez is back to provide more illogical inanity. Surprised our mate Dr Berenbach hasnt made an appearance as well, he should have plenty of time on his hands these days.

BTW, I personally think MSB is a really good company. CYP needs companies like MSB to spend the effort proving up MSC efficacy in various conditions. Its doing a great job of that and I hope it keeps doing just that. If it gets deals fantastic for MSB shareholders. I just think once they prove the market it leaves it open to a potentially better MSC approach to be used instead and I think that's here.

As to your fixation Lopez with this stock relative to your one, seems rather silly to me. Both MSB and CYP need MSC stem cell therapies to be accepted without question. The market is plenty big for multiple players so your rather simple us vs them position shown here regularly is pretty pointless.